Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Healthcare Sector Analysis

UpdatedFeb 27, 2026
DataAggregated Company Financials
Companies127
  • 7D-1.1%
  • 3M7.1%
  • 1Y17.6%
  • YTD-3.2%

Over the last 7 days, the Healthcare industry has dropped 1.1%, driven by a pullback from Curaleaf Holdings of 7.0%. In contrast, Redwood AI has gained 185%. This takes the industry's 12 month performance to a gain of 18%. Earnings are forecast to grow by 48% annually.

Sector Valuation and Performance

Has the Canadian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 27 Feb 2026CA$33.7bCA$17.6b-CA$2,049,953,693.4219.1x-16.4x1.9x
Sun, 25 Jan 2026CA$34.5bCA$17.5b-CA$2,183,751,086.2522.4x-15.8x2x
Tue, 23 Dec 2025CA$36.3bCA$19.2b-CA$2,212,842,927.4718.9x-16.4x1.9x
Thu, 20 Nov 2025CA$31.0bCA$19.3b-CA$2,177,523,621.0119x-14.2x1.6x
Sat, 18 Oct 2025CA$37.4bCA$19.5b-CA$2,329,064,864.3341.2x-16.1x1.9x
Mon, 15 Sep 2025CA$33.8bCA$19.4b-CA$2,309,057,574.7141.2x-14.7x1.7x
Wed, 13 Aug 2025CA$34.6bCA$19.7b-CA$2,693,832,620.1229.6x-12.8x1.8x
Fri, 11 Jul 2025CA$28.8bCA$19.5b-CA$2,784,539,802.2024.2x-10.3x1.5x
Sun, 08 Jun 2025CA$27.3bCA$19.5b-CA$2,819,021,856.8322.8x-9.7x1.4x
Tue, 06 May 2025CA$28.0bCA$19.5b-CA$2,751,753,447.1225.7x-10.2x1.4x
Thu, 03 Apr 2025CA$25.9bCA$20.0b-CA$2,844,739,177.0219.6x-9.1x1.3x
Sat, 01 Mar 2025CA$27.9bCA$20.0b-CA$2,661,900,478.1722.7x-10.5x1.4x
Mon, 27 Jan 2025CA$28.3bCA$19.8b-CA$2,714,894,200.5333.5x-10.4x1.4x
Wed, 25 Dec 2024CA$28.6bCA$19.8b-CA$2,727,840,320.7425x-10.5x1.4x
Fri, 22 Nov 2024CA$30.2bCA$19.9b-CA$2,935,805,391.9417.5x-10.3x1.5x
Sun, 20 Oct 2024CA$34.7bCA$19.4b-CA$2,973,499,232.9020.6x-11.7x1.8x
Tue, 17 Sep 2024CA$32.6bCA$19.3b-CA$2,972,871,887.6621.5x-11x1.7x
Thu, 15 Aug 2024CA$32.7bCA$19.2b-CA$3,138,609,899.9124.3x-10.4x1.7x
Sat, 13 Jul 2024CA$33.2bCA$19.1b-CA$3,643,946,419.7019.5x-9.1x1.7x
Mon, 10 Jun 2024CA$33.3bCA$19.4b-CA$3,302,737,566.3317.7x-10.1x1.7x
Wed, 08 May 2024CA$35.5bCA$19.3b-CA$4,002,758,670.3716.9x-8.9x1.8x
Fri, 05 Apr 2024CA$37.5bCA$19.4b-CA$4,010,353,073.3712.1x-9.4x1.9x
Sun, 03 Mar 2024CA$33.7bCA$19.3b-CA$4,757,965,284.4313.2x-7.1x1.7x
Tue, 30 Jan 2024CA$37.7bCA$20.0b-CA$7,662,267,258.0012.1x-4.9x1.9x
Thu, 28 Dec 2023CA$33.1bCA$19.9b-CA$7,630,057,060.0014.1x-4.3x1.7x
Sat, 25 Nov 2023CA$33.2bCA$20.2b-CA$7,856,534,753.0015.8x-4.2x1.6x
Mon, 23 Oct 2023CA$32.0bCA$20.0b-CA$8,402,080,042.0017.8x-3.8x1.6x
Wed, 20 Sep 2023CA$35.9bCA$20.5b-CA$8,918,982,525.0017.8x-4x1.8x
Fri, 18 Aug 2023CA$29.3bCA$20.5b-CA$9,118,486,763.0018.2x-3.2x1.4x
Sun, 16 Jul 2023CA$31.8bCA$20.5b-CA$10,798,326,060.0021.6x-2.9x1.5x
Tue, 13 Jun 2023CA$30.3bCA$20.7b-CA$11,510,904,014.0015.7x-2.6x1.5x
Thu, 11 May 2023CA$31.7bCA$20.5b-CA$11,341,287,758.0017x-2.8x1.5x
Sat, 08 Apr 2023CA$29.7bCA$21.5b-CA$11,323,867,930.0015.6x-2.6x1.4x
Mon, 06 Mar 2023CA$35.2bCA$21.1b-CA$11,719,226,086.0020x-3x1.7x
Price to Earnings Ratio

-3x


Total Market Cap: CA$35.2bTotal Earnings: -CA$11,719,226,086.00Total Revenue: CA$21.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Healthcare Sector Price to Earnings3Y Average -8.8x202420252026
Current Industry PE
  • Investors are optimistic on the Canadian Healthcare industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 1.6x is lower than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 5.9% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare sector?

CA Market2.71%
Healthcare-1.07%
Medical Equipment3.44%
Healthtech3.18%
Biotech1.91%
Healthcare Services0.71%
Life Sciences-0.094%
Pharma-3.89%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 53.2%, which is higher than its past year's earnings growth of 42.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 75% over the next 5 years.
  • This is better than its past earnings decline of 10% per year.
  • In contrast, the Biotech industry is expected to see its earnings decline by 2.2% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
AIRX Redwood AICA$4.30184.8%
+CA$93.5m		n/an/a
VRNO Verano HoldingsCA$1.5518.3%
+CA$87.2m		31.4%PS0.5x
WELL WELL Health TechnologiesCA$4.226.6%
+CA$66.1m		-26.5%PS0.9x
PRN Profound MedicalCA$10.6813.3%
+CA$45.4m		4.0%PS19.8x
CSH.UN Chartwell Retirement ResidencesCA$21.970.6%
+CA$44.3m		32.6%PE270.6x

Latest News

CSH.UN
CA$21.97
Chartwell Retirement Residences
7D
0.6%
1Y
32.6%
EXE
CA$24.15
Extendicare
7D
-1.9%
1Y
107.7%
GTII
CA$9.00
Green Thumb Industries
7D
-4.3%
1Y
-13.5%
TRUL
CA$8.95
Trulieve Cannabis
7D
-2.7%
1Y
41.8%

TRUL: Rescheduling To Schedule III Will Shape Future Upside Potential

Analysts have trimmed their price target on Trulieve Cannabis by a small amount to reflect a slightly lower fair value estimate of CA$14.69. This incorporates updated assumptions that include modestly adjusted revenue growth, profit margin outlook and future P/E expectations.
CL
CA$1.37
Cresco Labs
7D
-12.2%
1Y
6.2%
VRNO
CA$1.55
Verano Holdings
7D
18.3%
1Y
31.4%

VRNO: Expanding Retail Footprint And New License Will Drive Future Upside

Analysts have made a modest adjustment to their CA$ price target on Verano Holdings, reflecting updated assumptions about discount rates, revenue growth, profit margins and future P/E multiples. They are now presenting the stock’s outlook with a more refined view of its risk and earnings profile.
WELL
CA$4.22
WELL Health Technologies
7D
6.6%
1Y
-26.5%
CURA
CA$3.33
Curaleaf Holdings
7D
-7.0%
1Y
72.5%

CURA: Refinancing And Hemp Exit Will Support Wider Future Moat

Analysts have slightly adjusted their CA$ fair value estimate for Curaleaf Holdings to reflect updated assumptions on revenue growth, profit margins, and future P/E expectations. This has led to a modest change in the implied price target.
TSND
CA$0.92
TerrAscend
7D
-11.5%
1Y
26.0%

TSND: Union Chill Expansion Will Support Future Retail Scale And Margins

Analysts have trimmed their CA$ price target for TerrAscend, citing a slightly higher discount rate, a modestly reduced revenue outlook, and an improved profit margin profile that together reset expectations around the stock's future P/E level. What's in the News Closed the previously announced transaction with Union Chill Cannabis Company LLC, adding a high performing Hunterdon County dispensary and bringing TerrAscend's New Jersey retail footprint to four locations (Key Developments).
MSCL
CA$16.32
Satellos Bioscience
7D
7.0%
1Y
70.0%
PRN
CA$10.68
Profound Medical
7D
13.3%
1Y
4.0%

Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27%

Feb 13
Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27%
AIRX
CA$4.30
Redwood AI
7D
184.8%
1Y
n/a
HITI
CA$3.60
High Tide
7D
9.8%
1Y
0.8%
VREO
CA$0.65
Vireo Growth
7D
-4.4%
1Y
-4.4%
CWEB
CA$1.07
Charlotte's Web Holdings
7D
-17.1%
1Y
664.3%

Charlotte's Web Holdings, Inc. (TSE:CWEB) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected

Jan 28
Charlotte's Web Holdings, Inc. (TSE:CWEB) Stock Rockets 27% As Investors Are Less Pessimistic Than Expected
DRUG
CA$118.20
Bright Minds Biosciences
7D
2.7%
1Y
147.2%